| 1. |
Mosmann T, Cherwinski H, Bond M, Giedlin M, Coffman R. Two types of murine helper T-cell clone. I. Definition according to
profiles of lymphokine activities and secreted proteins. 1986. J Immunol 1986; 136:2348–2357.
|
| |
| 2. |
Xu H, Dilulio NA, Fairchild RL. T-cell populations primed by hapten sensitization in contact sensitivity are distinguished
by polarized patterns of cytokine production: IFN-γ producing (Tel) effector CD8+ T and IL-/IL-10 producing (Th2) negative
regulatory CD4+ T-cells. J Exp Med 1996;183:1001–1012.
|
| |
| 3. |
Dearman RJ, Basketter DA, Kimber I. Characterization of chemical allergens as a function of divergent cytokine secretion profiles
induced in mice. Toxicol Appl Pharmacol 1996;138:308–316.
|
| |
| 4. |
Dearman RJ, Moussavi A, Kemeny DM, Kimber I. Contribution of CD4+ and CD8+ T lymphocyte subsets to the secretion patterns
induced in mice during sensitization to contact and respiratory chemical allergens. Immunology 1996;89:502–510.
|
| |
| 5. |
Dieli F, Asherson GL, Sireci G, Dominici R, Sciré E, Salerno A. Development of IFN-γ-producing CD8+ T lymphocytes during contact
sensitivity. J Immunol 1997; 158:2567–2575.
|
| |
| 6. |
Warington RJ, Silviu-Dan F, Magro C. Accelerated cell-mediated immune reactions in penicillin allergy. J Allergy Clin Immunol
1993;92:626–628.
|
| |
| 7. |
Hertl M, Bohlen H, Jugert F, Boecker C, Knaup R, Merk HF. Predominance of epidermal CD8+ T lymphocytes in bullous cutaneous
reactions caused by β-Lactam antibiotics. J Invest Dermatol 1993;101:794–799.
|
| |
| 8. |
Hertl M, Merk HF. Lymphocyte activation in cutaneous drug reactions. J Invest Dermatol 1995;105:95S–98S.
|
| |
| 9. |
Brander C, Mauri-Hellweg D, Bettens F, Rolli H, Goldman M, Pichler WJ. Heterogenous T-cell responses to β-Lactam-modified
self-structures are observed in penicillin-allergic individuals. J Immunol 1995;155:2670–2678.
|
| |
| 10. |
Mauri-Hellweg D, Bettens F, Mauri D, Brander C, Hunziker T, Pichler WJ. Activation of drug-specific CD4+ and CD8+ T-cells
in individuals allergic to sulfonamides, phenytoin, and carbamazepine. J Immunol 1995; 155:462–472.
|
| |
| 11. |
Hertl M, Geisel J, Boecker C, Merk HF. Selective generation of CD8+ T-cell clones from the peripheral blood of patients with
cutaneous reactions to betalactam antibiotics. Br J Dermatol 1993;128:619–626.
|
| |
| 12. |
Levine BB, Ovary Z. Studies on the mechanism of the formation of the penicillin antigen. J Exp Med 1961; 114:875–904.
|
| |
| 13. |
Yvon M, Anglade P, Wal J-M. Identification of the binding sites of benzyl penicilloyl, the allergenic metabolite of penicillin,
on the serum albumin molecule. FEBS Lett 1990;263:237–240.
|
| |
| 14. |
Weltzien HU, Padovan E. Molecular features of penicillin allergy. J Invest Dermatol 1998; 110:203–206.
|
| |
| 15. |
Pichler W. Delayed Drug Hypersensitivity Reactions. Ann Intern Med 2003; 139:683–693.
|
| |
| 16. |
Coombs PR, Gell PG. Classification of allergic reactions responsible for clinical hypersensitivity and disease. In: Gell RR,
ed. Clinical Aspects of Immunology. Oxford: Oxford Univ Press, 1968, pp. 575–596.
|
| |
| 17. |
Posadas S, Leyva L, Torres M, et al. Subjects with allergic reactions to drug show in vivo polarized patterns of cytokine
expression depending on the chronology of the clinical reaction. J Allergy Clin Immunol 2000; 106:769–776.
|
| |
| 18. |
Gaspard I, Guinnepain MT, Laurent J, et al. IL-and IFN-γ mRNA Induction in peripheral lymphocytes specific for γ-lactam antibiotics
in immediate or delayed hypersensitivity reactions. J Clin immunol 2000;20:107–116.
|
| |
| 19. |
Brugnolo F, Annunziato F, Sampognaro S, et al. Highly Th2-skewed cytokine profile of β-lactam-specific T-cells from nonatopic
subjects with adverse drug reactions. J Immunol 1999; 163:1053–1059.
|
| |
| 20. |
Britschgi M, Steiner U, Schmid S, et al. T-cell involvement in drug-induced acute generalized exanthematous pustulosis. J
Clin Invest 2001;107:1433–1441.
|
| |
| 21. |
Schaerli P, Britschgi M, Keller M, et al. Characterization of Human T-cells That Regulate Neutrophilic Skin Inflammmation.
J Immunol 2004;173:2151–2158.
|
| |
| 22. |
Pichler W, Yawalkar N, Britschgi M, et al. Cellular and molecular pathophysiology of cutaneous drug reactions. Am J Clin Dermatol
2002;3:229–238.
|
| |
| 23. |
Choquet-Kastylevsky G, Intrator L, Chenal C. Increased levels of interleukin 5 are associated with the generation of eosinophilia
in drug-induced hypersensitivity syndrome. Br J Dermatol 1998;139:1026–1032.
|
| |
| 24. |
Leyva L, Torres M, Posadas S, et al. Anticonvulsivant-induced toxic epidermal necrolysis: monitoring the immunological response.
J Allergy Clin Immunol 2000; 105:157–165.
|
| |
| 25. |
Lin RY. A perspective on penicillin allergy. Arch Intern Med 1992;152:930–937.
|
| |
| 26. |
Vega JM, Bianca M, Garcia JJ, et al. Immediate allergic reaction to amoxicillin. Allergy 1994;49:317–322.
|
| |
| 27. |
Boguniewicz M, Leung DYM. Management of the patient with allergic reactions to antibiotics. Pediatr Pulmonol 1992; 12:113–122.
|
| |
| 28. |
Romano A, Di Fonso M, Papa G, et al. Evaluation of adverse cutaneous reactions to aminopenicillins with emphasis on those
manifested by maculopapular rashes. Allergy 1995;50:113–118.
|
| |
| 29. |
Barbaud A, Bene MC, Faure G. Immunological physiopathology of cutaneous adverse drug recations. Eur J Dermatol 1997;7:319–323.
|
| |
| 30. |
Scala E, Giani M, Pastore S, et al. Distinct delayed response to β-methasone and penicillin-G in the same patient. Allergy
2003;58:439–444.
|
| |
| 31. |
Pulendran B, Palucka K, Banchereau J. Sensing pathogens and tuning immune responses. Science 2001;293:253–256.
|
| |
| 32. |
Banchereau J, Fay J, Pascual V, Palucka AK. Dendritic cells: controllers of the immune system and a new promise for immunotherapy.
2003;252:226–235.
|
| |
| 33. |
O’Garra A. Cytokines induce the development of functionally heterogenous T helper cell subsets. Immunity 1998;8:275–283.
|
| |
| 34. |
Macatonia S, Hosken N, Litton M, et al. Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+
T-cells. 1995. J Immunol 1995;154:5071–5079.
|
| |
| 35. |
Robinson D, Shibuya K, Mui A, et al. IGIF does not drive Th1 development, but synergizes with IL-12 for IFN-γ production,
and activates IRAK and NF-kB. Immunity 1997;7:571–581.
|
| |
| 36. |
Abehsira-Amar O, Gibert M, Joliy M, Theze J, Jankovic D. IL-plays a dominant role in the differential development of Tho into
Th1 and Th2 cells. J Immunol 1992; 148:3820–3829.
|
| |
| 37. |
Barton GM, Medzhitov R. Control of adaptive immune responses by Toll-like receptors. Curr Opin Immunol 2002;14:380–383.
|
| |
| 38. |
Medzhitov R, Janeway C. The Toll receptor family and microbial recognition. Trends Microbiol. 2000;8:452–456.
|
| |
| 39. |
Pasare C, Medzhitov R. Toll-like receptors and acquired immunity. Semin Immunol 2004; 16:23–26.
|
| |
| 40. |
Schnare M, Barton GM, Holt AC, Takeda K, Akira S, Medzhitov R. Toll-like receptors control activation of adaptive immune responses.
Nat Immunol 2001;2:947–950.
|
| |
| 41. |
Kaisho T, Akira S. Regulation of dendritic cell function through Toll-like receptors. Curr Mol Med 2003;3:373–385.
|
| |
| 42. |
Kadowaki N, Ho S, Antonenko S, Malefyt RW, Kastelein RA, Bazan F, Liu YJ. Subsets of human dendritic cell precursors express
different toll-like receptors and respond to different microbial antigens. J Exp Med 2001;194:863–869.
|
| |
| 43. |
Parronchi P, De Carli M, Manetti R, et al. IL-and IFN (alpha and gamma) exert opposite regulatory effects on the development
of cytolytic potential by Th1 or Th2 human T-cell clones. J Immunol 1992; 149:2977–2983.
|
| |
| 44. |
Schandene L, Del Prete GF, Cogan E, et al. Recombinant interferon-alpha selectively inhibits the production of interleukin-5
by human CD4+ T-cells. J Clin Invest 1996; 15:309–315.
|
| |
| 45. |
Parronchi P, Mohapatra S, Sampognaro S, et al. Effects of interferon-alpha on cytokine profile, T-cell receptor repertoire
and peptide reactivity of human allergen-specific T-cells. 1996. Eur J Immunol 1996;26:697–703.
|
| |
| 46. |
Del Prete G, De Carli M, Almerigogna F, Giudizi M, Biagiotti R, Romagnani S. Human IL-10 is produced by both type 1 helper
(Th1) and type 2 helper (Th2) T-cell clones and inhibits their antigen-specific proliferation and cytokine production. 1993.
J Immunol 1993;150:353–360.
|
| |
| 47. |
Glimcher LH, Murphy KM. Lineage commitment in the immune system: the T helper lymphocyte grows up. Genes Dev 2000; 14:1693–1711.
|
| |
| 48. |
Maggi E, Parronchi P, Manetti R, et al. Reciprocal regulatory effects of IFN-gamma and IL-4 on the in vitro development of
human Th1 and Th2 clones. J Immunol 1992;148:2142–2147.
|
| |
| 49. |
Pardoll DM, Topalian SL. The role of CD4+ T-cell responses in antitumor immunity. Curr Opin Immunol 1998; 10:588–594.
|
| |
| 50. |
Kemp M, Kurtzhals J, Bendtzen K, et al. Leishmania donovani-reactive Th1-and Th2-like T-cell clones from individuals who have
recovered from visceral leishmaniasis. 1993. Infect Immun 1993;61:1069–1073.
|
| |
| 51. |
Miralles G, Stoeckle M, McDermott D, Finkelman F, Murray H. Th1 and Th2 cell-associated cytokines in experimental visceral
leishmaniasis. Infect Immun 1994;62:1058–1063.
|
| |
| 52. |
Sjolander A, Baldwin TM, Curtis JM, Handman E. Induction of a Th1 immune response and simultaneous lack of activation of a
Th2 response are required for generation of immunity to leishmaniasis. J Immunol 1998; 160:3949–3957.
|
| |
| 53. |
Hilkens CM, Schlaak JF, Kerr IM. Differential responses to IFN-alpha subtypes in human T-cells and dendritic cells. J Immunol
2003;171:5255–5263.
|
| |
| 54. |
Padovan E, Spagnoli GC, Ferrantini M, Heberer M. IFN-alpha2a induces IP-10/CXCL10 and MIG/CXCL9 production in monocyte-derived
dendritic cells and enhances their capacity to attract and stimulate CD8+ effector T-cells. J Leukoc Biol 2002;71:669–676.
|
| |
| 55. |
Toellner K-M, Luther SA, Sze DMY, et al T Helper 1 (Th1) and Th2 characteristics start to develop during T-cell priming and
are associated with an immediate ability to induce immunoglobulin class switching. J Exp Med 1998; 187: 1193–1204.
|
| |
| 56. |
Del Prete G, De Carli M, Ricci M, Romagnani S. Helper activity for immunoglobulin synthesis of T helper type 1 (Th1) and Th2
human T-cell clones: the help of Th1 clones is limited by their cytolytic capacity. J Exp Med 1991; 174: 809–813.
|
| |
| 57. |
Finkelman F Katona I, Mosmann T, Coffman R. IFN-gamma regulates the isotypes of Ig secreted during in vivo humoral immune
responses. J Immunol 1988; 140:1022–1027.
|
| |
| 58. |
Rousset F, Malefijt RW, Slierendregt B, et al. Regulation of Fc receptor for IgE (CD23) and class II MHC antigen expression
on Burkitt’s lymphoma cell lines by human IL-4 and IFN-gamma. J Immunol 1988; 140:2625–2632.
|
| |
| 59. |
Vukmanovic-Stejic M, Vyas B, Gorak-Stolinska P, Noble A, Kemeny DM. Human Tc1 and Tc2/Tc0 CD8 T-cell clones display distincT-cell
surface and functional phenotypes. Blood 2000;95:231–240.
|
| |
| 60. |
Halverson DC, Schwartz GN, Carter C, Gress RE, Fowler DH. In vitro generation of allospecific human CD8+ T-cells of Tc1 and
Tc2 phenotype. Blood 1997;90:2089–2096.
|
| |
| 61. |
Shevach EM. Regulatory T-cells in autoimmmunity. Annu Rev Immunol 2000; 18:423–449.
|
| |
| 62. |
Shevach EM. Regulatory T-cells. Introduction. Semin Immunol 2004; 16:69–71.
|
| |
| 63. |
Theofilopoulos AN, Koundouris S, Korio DH, Lawson BR. The role of IFNgamma in systemic lupus erythematosus: a challenge to
the Th1/Th2 paradigm in autoimmunity. Arthritis Res 2001;3:136–141.
|
| |